IP Library Granted Patent US 9,468,497
Granted Patent B2
US 9,468,497 · App. 15/069,868 · Granted Oct 18, 2016

Methods for monopolar renal neuromodulation

Inventors: Denise Zarins (Saratoga, CA); Hanson Gifford, III (Woodside, CA); Mark Deem (Mountain View, CA); Howard R. Levin (Teaneck, NJ); Mark Gelfand (New York, NY); Nicolas Zadno (Fremont, CA)
Assignee: Medtronic Ardian Luxembourg S.a.r.l.
A61B18/1492A61B18/16A61B2018/00267A61B2018/00434A61B2018/00511A61B2018/00577A61B2018/00613A61B2018/00642A61B2018/1253
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,468,497
App. No.
15/069,868
Granted
Oct 18, 2016
Kind
B2
Abstract

Methods and apparatus are provided for monopolar neuromodulation, e.g., via a pulsed electric field. Such monopolar neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, monopolar neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such monopolar neuromodulation is performed bilaterally.

Claims (29)

1. A method for treating hypertension in a human patient via renal denervation, the method comprising:

intravascularly placing a monopolar electrode at least substantially proximate to a post-ganglionic nerve that innervates a kidney of a patient;

electrically coupling a ground electrode to an exterior of the patient; and

delivering an electric field between the monopolar electrode and the ground electrode such that the resulting electric field attenuates neural communication along the post-ganglionic nerve,

wherein delivering the electric field results in a therapeutically beneficial reduction in blood pressure of the patient.

2. The method of claim 1 wherein intravascularly placing a monopolar electrode at least substantially proximate to a post-ganglionic nerve comprises intravascularly placing the monopolar electrode within a renal artery via a femoral artery and an aorta of the patient.

3. The method of claim 1 , further comprising removing the electrode from the patient after delivering the electric field.

4. The method of claim 1 wherein attenuating neural communication along the post-ganglionic nerve comprises ablating the nerve.

5. The method of claim 1 wherein attenuating neural communication along the post-ganglionic nerve comprises partially ablating the nerve.

6. The method of claim 1 wherein attenuating neural communication along the post-ganglionic nerve comprises blocking neural traffic to and/or from the kidney.

7. The method of claim 1 wherein the monopolar electrode is carried by an expandable basket, and wherein intravascularly placing a monopolar electrode at least substantially proximate to a post-ganglionic nerve comprises intravascularly delivering the expandable basket to a renal artery of the patient in a low-profile configuration and transforming the basket to a deployed configuration to place the electrode in contact with a wall of the renal artery.

8. The method of claim 1 , further comprising monitoring a parameter of tissue within the patient before and during delivery of the electric field.

9. The method of claim 8 , further comprising modifying delivery of the electric field in response to the monitored parameter.

10. A method for at least partially denervating a kidney of a human patient, the method comprising:

transluminally delivering a monopolar electrode to a renal blood vessel of the patient and in proximity to a post-ganglionic nerve that innervates the kidney;

electrically coupling a ground electrode to an exterior of the patient; and

delivering an electric field between the monopolar electrode and the ground electrode to at least partially denervate the kidney,

wherein at least partially denervating the kidney results in a therapeutically beneficial reduction in blood pressure of the patient.

11. The method of claim 10 wherein transluminally delivering a monopolar electrode to a renal blood vessel of the patient comprises:

positioning an expandable member carrying two or more electrodes within a renal artery of the patient in a low-profile delivery arrangement; and

transforming the expandable member into a treatment arrangement to place the two or more electrodes in apposition with a wall of the renal artery before delivering the electric field.

12. The method of claim 11 wherein the expandable member comprises a basket.

13. The method of claim 10 wherein transluminally delivering a monopolar electrode to a renal blood vessel of the patient comprises placing the monopolar electrode in contact with a wall of a renal artery of the patient and proximate to the post-ganglionic nerve.

14. The method of claim 10 wherein transluminally delivering a monopolar electrode to a renal blood vessel of the patient comprises transluminally delivering a catheter carrying the monopolar electrode to a renal artery of the patient via a guidewire.

15. The method of claim 14 wherein the catheter comprises a basket with a plurality of struts and monopolar electrodes on each strut, and wherein transluminally delivering the catheter comprises delivering the basket to the renal artery in a delivery arrangement and transforming the basket to a deployed configuration to place the monopolar electrodes carried by the struts in apposition with an inner wall of the renal artery.

16. The method of claim 10 , further comprising removing the monopolar electrode from the patient after delivering the electric field.

17. The method of claim 10 wherein delivering an electric field to at least partially denervate the kidney comprises thermally altering the post-ganglionic nerve via the electric field.

18. The method of claim 10 wherein delivering an electric field to at least partially denervate the kidney comprises partially ablating the post-ganglionic nerve.

19. The method of claim 10 wherein delivering an electric field to at least partially denervate the kidney comprises ablating the post-ganglionic nerve.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2016
From: DEMARAIS, DENISE; GIFFORD, HANSON, III; DEEM, MARK; LEVIN, HOWARD R.; GELFAND, MARK; ZADNO, NICOLAS
To: ARDIAN, INC.
Reel/Frame 038961/0158 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2016
From: MEDTRONIC ARDIAN LLC
To: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
Reel/Frame 038961/0414 →
CHANGE OF NAME Recorded Jun 20, 2016
From: ARDIAN, INC.
To: MEDTRONIC ARDIAN LLC
Reel/Frame 039092/0380 →
Continuity (16)
Continuation 14548810 · Nov 20, 2014
Continuation 13958450 · Aug 2, 2013
Continuation 13371285 · Feb 10, 2012
Division 11403329 · Apr 13, 2006
Continuation In Part 11129765 · May 13, 2005
Continuation In Part 10408665 · Apr 8, 2003
Continuation In Part 11189563 · Jul 25, 2005
Continuation In Part 11266993 · Nov 4, 2005
Continuation In Part 11363867 · Feb 27, 2006
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60624793 · Nov 2, 2004
Provisional Application 60442970 · Jan 29, 2003
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60370190 · Apr 8, 2002
Provisional Application 60813589 · Dec 29, 2005
Related Publication 20160184012A1 · Jun 30, 2016